News Sentiment

BNR sentiment intelligence

Burning Rock Biotech Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 46 Balanced news tone 33 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 7.25 Week of 19 Jun 2026
Weighted tone 46/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 33

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-15.6% over one week, -50.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Burning Rock Biotech Ltd (BNR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -15.6% Price reacting lower
Trend fit Trend inactive -50.0% over four weeks
Fair value -28.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 16
Negative 12

Relevance

Why the article matched

Direct first
Direct company coverage 33
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingKey 7
Stock Titan 6
MarketBeat 3
Sahm 2
scanx.trade 2
Moomoo 2
Benzinga 1
The Globe and Mail 1

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 9
Deals and strategy 3
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 33
TradingKey Direct company coverage

Burning Rock Biotech Ltd (BNR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Burning Rock Biotech Ltd (BNR), detailing its current price momentum score, support and resistance levels, and indicator and moving average readings. It highlights that BNR's stock is trading between resistance at 14.77 and support at

Tone
Negative 28/100
Event
Market update
Published
19 Jun 2026 05:09
Source
TradingKey
TradingKey Direct company coverage

Burning Rock Biotech Ltd (BNR) Institutional Confidence

Burning Rock Biotech Ltd (BNR) currently has an institutional shareholding score of 3.00, placing it 56th out of 76 in the Healthcare Providers & Services industry. The institutional shareholding proportion is 45.78%, showing a 1.67% decrease quarter-over-quarter. James Simons is

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 04:39
Source
TradingKey
TradingKey Direct company coverage

Burning Rock Biotech Ltd (BNR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Burning Rock Biotech Ltd (BNR), detailing its financial performance by business segments and regional contributions for fiscal years 2018 and 2019. It notes that relevant data for these periods have not yet been disclosed by the compa

Tone
Negative 33/100
Event
Earnings
Published
17 Jun 2026 20:39
Source
TradingKey
TradingKey Direct company coverage

Burning Rock Biotech Ltd (BNR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Burning Rock Biotech Ltd (BNR) stock information, focusing on its dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years. However, it lists several "Merger" type stock sp

Tone
Negative 40/100
Event
Deals and strategy
Published
17 Jun 2026 19:39
Source
TradingKey
Benzinga Direct company coverage

Why These High-Flying Stocks Came Back To Earth

Shares of several U.S.-traded Chinese small- and midcap companies – Here Group, Zepp Health, Burning Rock Biotech, and So-Young International – saw meteoric rises last year but have since given back most of their gains. This phenomenon, which bears resemblances to speculative "me

Tone
Negative 38/100
Event
Market update
Published
12 Jun 2026 12:38
Source
Benzinga
Sahm Direct company coverage

Earnings Scheduled For June 9, 2026

This article lists companies scheduled to report earnings on June 9, 2026. It details earnings per share and revenue estimates for companies reporting both before and after the bell, including Nathan's Famous, Burning Rock Biotech, Titan Machinery, Academy Sports, Casey's General

Tone
Neutral 50/100
Event
Earnings
Published
12 Jun 2026 04:14
Source
Sahm
scanx.trade Direct company coverage

Burning Rock Q1 2026 revenue falls 18.9% to RMB107.9 million

Burning Rock Biotech reported an unchanged net loss per share of $(0.20) for Q1 2026, as sales decreased by 14.67% to $15.649 million. This revenue decline was primarily due to lower performance in its central laboratory, in-hospital, and pharma R&D channels. Despite a 14.0% redu

Tone
Negative 29/100
Event
Earnings
Published
09 Jun 2026 13:11
Source
scanx.trade
grafa.com Direct company coverage

Burning Rock reports 19% decline in Q1 2026 revenue

Burning Rock Biotech experienced an 18.9% decline in Q1 2026 revenue, totaling RMB107.9 million, due to lower volumes in diagnostic testing and pharmaceutical services. Despite cost controls that reduced operating expenses by 14%, the company's net loss widened to RMB17.5 million

Tone
Negative 28/100
Event
Earnings
Published
09 Jun 2026 12:04
Source
grafa.com
Stock Titan Direct company coverage

Cancer test firm Burning Rock posts Q1 sales drop, wider loss

Burning Rock (NASDAQ: BNR) reported a significant decline in Q1 2026 revenues to RMB107.9 million, an 18.9% year-over-year decrease, with all segments experiencing a drop. Despite a 14.0% reduction in operating expenses, the company's net loss widened to RMB17.5 million. This qua

Tone
Negative 30/100
Event
Market update
Published
09 Jun 2026 11:10
Source
Stock Titan
GlobeNewswire Direct company coverage

Burning Rock Reports First Quarter 2026 Financial Results

Burning Rock Biotech Limited announced its financial results for the first quarter of 2026, reporting revenues of RMB107.9 million, an 18.9% decrease year-over-year. The decrease was primarily due to declines in central laboratory business and pharma research and development serv

Tone
Neutral 50/100
Event
Earnings
Published
09 Jun 2026 10:10
Source
GlobeNewswire
Stock Titan Direct company coverage

Burning Rock (NASDAQ: BNR) posts Q1 2026 loss as revenue declines

Burning Rock Biotech (NASDAQ: BNR) reported a significant revenue decline and widened net loss for Q1 2026. Revenues fell 18.9% year-over-year to RMB107.9 million (US$15.6 million), while the net loss increased to RMB17.5 million (US$2.5 million). Despite efforts to control opera

Tone
Negative 30/100
Event
Earnings
Published
09 Jun 2026 10:10
Source
Stock Titan
Simply Wall Street Direct company coverage

Burning Rock Biotech (Nasdaq:BNR) - Stock Analysis

Burning Rock Biotech (Nasdaq:BNR) develops and sells cancer therapy selection tests and has a market cap of US$95.7m. The company's stock has been volatile, showing a 152.5% increase over one year but a 65.13% decrease over three months. Recent developments include NMPA approval

Tone
Neutral 50/100
Event
Regulatory and legal
Published
07 Jun 2026 12:39
Source
Simply Wall Street
Moomoo Direct company coverage

Burning Rock Announces Founder's Purchase of Its ADSs

Burning Rock Biotech Limited announced that its founder and CEO, Mr. Yusheng Yao, purchased 200,000 American Depositary Shares (ADSs) on the open market. This purchase reflects his confidence in the company's long-term business prospects and growth potential.

Tone
Positive 68/100
Event
Market update
Published
29 May 2026 20:39
Source
Moomoo
Stock Titan Direct company coverage

Kynam Capital (BNR) reports 1.23M ADSs, representing 13.97% stake

Kynam Capital Management, LP, along with Kynam Capital Management GP, LLC and Yue Tang, has disclosed a beneficial ownership of 1,227,555 American Depositary Shares (ADSs) in Burning Rock Biotech Ltd (BNR), representing 13.97% of the class. This information was reported in an ame

Tone
Neutral 50/100
Event
Deals and strategy
Published
15 May 2026 19:38
Source
Stock Titan
Stock Titan Direct company coverage

CRCM entities report ADS holdings in Burning Rock Biotech (BNR) — ~3% stakes

CRCM-related entities have filed an amendment to a Schedule 13G/A, disclosing beneficial ownership of American Depository Shares (ADSs) in Burning Rock Biotech (BNR). These filings indicate shared dispositive power over 275,025 and 282,097 ADS equivalents, representing approximat

Tone
Neutral 50/100
Event
Market update
Published
13 May 2026 21:39
Source
Stock Titan
TradingView Direct company coverage

ETFs Investing in Burning Rock Biotech Ltd. Sponsored ADR Stocks

This article lists ETFs that invest in Burning Rock Biotech Ltd. Sponsored ADR stocks, providing details such as market value, weight, issuer, management style, expense ratio, and AUM for each fund. The purpose is to demonstrate how ETFs can make investing in such stocks more acc

Tone
Neutral 50/100
Event
Market update
Published
01 May 2026 06:39
Source
TradingView
Moomoo Direct company coverage

Burning Rock Biotech | 20-F: FY2025 Annual Report

This article provides immediate access to Burning Rock Biotech's 20-F Annual Report for Fiscal Year 2025. The content is explicitly noted as a direct document, indicating it contains the full financial and operational disclosures from the company.

Tone
Neutral 50/100
Event
Market update
Published
30 Apr 2026 10:08
Source
Moomoo
Sahm Direct company coverage

Burning Rock Publishes 2025 Annual Report on Form 20-F

Burning Rock Biotech Limited announced it filed its Annual Report on Form 20-F for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission on April 28, 2026. The report is accessible on the SEC and company websites. Shareholders can request a hard copy

Tone
Neutral 50/100
Event
Market update
Published
28 Apr 2026 19:09
Source
Sahm
Stock Titan Direct company coverage

Burning Rock posts 2025 Form 20-F, offers free hard copies

Burning Rock Biotech (NASDAQ: BNR) filed its Annual Report on Form 20-F for the year ended December 31, 2025, on April 28, 2026. This filing is accessible on the SEC website and the company's investor site and includes audited consolidated financial statements. Shareholders and A

Tone
Negative 28/100
Event
Market update
Published
28 Apr 2026 10:38
Source
Stock Titan
The Manila Times Direct company coverage

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Biotech Limited announced that its founder, chairman, and CEO, Mr. Yusheng Han, purchased 31,487 of the company's ADSs for $546,603.90. This brings his total purchases across two consecutive post-earnings trading windows to 72,733 ADSs for over $1.35 million, demonst

Tone
Positive 73/100
Event
Market update
Published
08 Apr 2026 22:38
Source
The Manila Times
GuruFocus Direct company coverage

Insider Buying: Yusheng Han Acquires Shares of Burning Rock Biot

Yusheng Han, a Director at Burning Rock Biotech Ltd (BNR), purchased 314,870 shares of the company on March 31, 2026, increasing his total holdings to 17,672,676 shares. This transaction follows a pattern of insider buying with 1 insider buy and 0 sells over the past year for BNR

Tone
Positive 61/100
Event
Market update
Published
02 Apr 2026 18:13
Source
GuruFocus
MarketBeat Direct company coverage

Burning Rock Biotech (NASDAQ:BNR) Director Purchases $5,466,143.20 in Stock

Burning Rock Biotech (NASDAQ:BNR) Director Yusheng Han recently purchased 314,870 shares of the company's stock for over $5.4 million, increasing his total holdings to 17,672,676 shares. The transaction, disclosed on March 31st, occurred at an average price of $17.36 per share. D

Tone
Neutral 50/100
Event
Market update
Published
02 Apr 2026 15:10
Source
MarketBeat
Stock Titan Direct company coverage

Director Han Yusheng adds 314,870 Burning Rock Biotech (BNR) shares

Burning Rock Biotech Ltd Director Han Yusheng acquired 314,870 shares through an open-market purchase at a weighted average price of $17.36 per share. This transaction, totaling over $5.4 million, significantly increases his direct holdings to 17,672,676 shares, signaling strong

Tone
Positive 87/100
Event
Market update
Published
02 Apr 2026 11:10
Source
Stock Titan
Investing.com India Direct company coverage

Burning Rock CEO purchases $546,604 in company shares By Investing.com

Burning Rock Biotech Limited's CEO, Yusheng Han, has purchased 31,487 American Depositary Shares (ADSs) for over $546,000 in open market transactions. This recent acquisition, combined with a previous one, brings his total purchases to 72,733 ADSs worth more than $1.35 million. T

Tone
Positive 74/100
Event
Deals and strategy
Published
02 Apr 2026 11:10
Source
Investing.com India
MarketBeat Direct company coverage

Burning Rock Biotech (BNR) Expected to Announce Earnings on Tuesday

Burning Rock Biotech (BNR) is set to announce its Q4 2025 earnings on Tuesday, March 31st, with analysts expecting a loss of ($2.2875) per share on revenue of $19.20 million. The company's stock has recently traded down, and it faces negative financial metrics and an average "Sel

Tone
Neutral 50/100
Event
Earnings
Published
29 Mar 2026 18:09
Source
MarketBeat